Stay updated on Insulin Efsitora Alfa vs Insulin Degludec in Type 1 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Insulin Efsitora Alfa vs Insulin Degludec in Type 1 Diabetes Clinical Trial page.

Latest updates to the Insulin Efsitora Alfa vs Insulin Degludec in Type 1 Diabetes Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedRecord history now indicates the study is no longer recruiting participants, marking the end of enrollment. The history also adds a page revision note (v3.6.0) and removes the previous revision note (v3.5.5) from the record.SummaryDifference0.3%

- Check16 days agoChange DetectedThe page's revision number was updated from v3.5.4 to v3.5.5, reflecting a backend update to the page. No study data or visible content was changed.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page's revision label changed from v3.5.3 to v3.5.4, indicating a new build of the study history page.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page’s footer/interface version was updated from “Revision: v3.5.2” to “Revision: v3.5.3.” This represents a technical release/update rather than a change to the clinical trial record itself.SummaryDifference0.1%

- Check66 days agoChange DetectedAdded Revision: v3.5.2; removed Revision: v3.5.0 from the history.SummaryDifference0.1%

- Check95 days agoChange DetectedAdded a new revision entry v3.5.0 to the record history and removed revision v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Insulin Efsitora Alfa vs Insulin Degludec in Type 1 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Insulin Efsitora Alfa vs Insulin Degludec in Type 1 Diabetes Clinical Trial page.